Neuromuscular Blocking Agent (NMBA) Market Report

Global and China Neuromuscular Blocking Agent (NMBA) Industry Market Research Report (2017-2028)

  • POSTDATE：Nov 17, 2022
  • PAGES：170
  • REPORT CODE：GMM1382536
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Neuromuscular Blocking Agent (NMBA) industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions along with the strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    Please note that the figures and tables shown in the sample are just for the purpose of demonstration, which may differ from those in the final report.

    Competitive Landscape:

    • Abbott Laboratories

    • Hengrui Pharmaceutical

    • Somerset Therapeutics

    • Guike Pharmaceutical

    • GlaxoSmithKline

    • Nanjing King-Friend

    • Sandoz

    • Fresenius Kabi

    • AbbVie

    • Pfizer

    • Shanghai Pharmaceuticals

    • Themis Medicare

    Region:

    • China

    • North America

    • Europe

    • APAC

    • Latin America, Middle East and Africa

    Type:

    • Depolarizing

    • Non-depolarizing

    Application:

    • Hospital

    • Clinic

    • Pharmacy

    • Others

  • Table of Content

    Chapter 1 Industry Overview & Development Status in Global and China Market

    • 1.1 Neuromuscular Blocking Agent (NMBA) Industry Overview

      • 1.1.1 Neuromuscular Blocking Agent (NMBA) Market Scope and Market Segments

      • 1.1.2 Neuromuscular Blocking Agent (NMBA) Industry Characteristics

      • 1.1.3 Global and China Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

      • 1.1.4 Global and China Neuromuscular Blocking Agent (NMBA) Production Value and Growth Rate (2017-2028)

    • 1.2 Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate by Type (2017-2028)

      • 1.2.1 Depolarizing

      • 1.2.2 Non-depolarizing

    • 1.3 Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate by Application (2017-2028)

      • 1.3.1 Hospital

      • 1.3.2 Clinic

      • 1.3.3 Pharmacy

      • 1.3.4 Others

    • 1.4 Market Analysis by Region

      • 1.4.1 North America Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.2 Europe Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.3 APAC Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

      • 1.4.4 Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

    • 1.5 Global Neuromuscular Blocking Agent (NMBA) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

      • 1.5.1 Global Neuromuscular Blocking Agent (NMBA) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • 1.6 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Price, Sales Value (2017-2028)

      • 1.6.1 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Price, Sales Value (2017-2028)

    Chapter 2 Global Neuromuscular Blocking Agent (NMBA) Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Challenges and Restraints

      • 2.1.2 Opportunities and Potentialities

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape

      • 2.2.1 Market Concentration Rate Analysis

      • 2.2.2 Neuromuscular Blocking Agent (NMBA) Industry Porter's Five Forces Model Analysis

      • 2.2.3 Neuromuscular Blocking Agent (NMBA) Industry PEST Analysis

    • 2.3 Neuromuscular Blocking Agent (NMBA) Industry Chain Analysis

      • 2.3.1 Raw Material Supplies

      • 2.3.2 Neuromuscular Blocking Agent (NMBA) Downstream Market Analysis

      • 2.3.3 Upstream and Downstream Impacts on Neuromuscular Blocking Agent (NMBA) Industry

    Chapter 3 Global and China Neuromuscular Blocking Agent (NMBA) Market, by Manufacturer

    • 3.1 Global and China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Market Share, by Manufacturer (2021&2022)

      • 3.1.1 Global and China Neuromuscular Blocking Agent (NMBA) Sales Volume, by Manufacturer (2021&2022)

      • 3.1.2 Global and China Neuromuscular Blocking Agent (NMBA) Sales Value, by Manufacturer (2021&2022)

      • 3.1.3 Global and China Neuromuscular Blocking Agent (NMBA) Market Share, by Manufacturer (2021&2022)

    • 3.2 SWOT Analysis on Global and China Neuromuscular Blocking Agent (NMBA) Market Top 3 Players

    Chapter 4 Global and China Neuromuscular Blocking Agent (NMBA) Market, by Type (2017-2028)

    • 4.1 Neuromuscular Blocking Agent (NMBA) Market Trend, by Type

    • 4.2 Global Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Volume and Market Share, by Type (2017-2028)

      • 4.2.2 Global Neuromuscular Blocking Agent (NMBA) Sales Value and Market Share, by Type (2017-2028)

      • 4.2.3 Global Neuromuscular Blocking Agent (NMBA) Price Trend, by Type (2017-2028)

    • 4.3 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value, Market Share and Price Trend, by Type

      • 4.3.1 China Neuromuscular Blocking Agent (NMBA) Sales Volume and Market Share, by Type (2017-2028)

      • 4.3.2 China Neuromuscular Blocking Agent (NMBA) Sales Value and Market Share, by Type (2017-2028)

      • 4.3.3 China Neuromuscular Blocking Agent (NMBA) Price Trend, by Type (2017-2028)

    Chapter 5 Global and China Neuromuscular Blocking Agent (NMBA) Market, by Application (2017-2028)

    • 5.1 Downstream Market Overview

    • 5.2 Global Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Market Share, by Application

      • 5.2.1 Global Neuromuscular Blocking Agent (NMBA) Sales Volume and Market Share, by Application (2017-2028)

      • 5.2.2 Global Neuromuscular Blocking Agent (NMBA) Sales Value and Market Share, by Application (2017-2028)

    • 5.3 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Market Share, by Application

      • 5.3.1 China Neuromuscular Blocking Agent (NMBA) Sales Volume and Market Share, by Application (2017-2028)

      • 5.3.2 China Neuromuscular Blocking Agent (NMBA) Sales Value and Market Share, by Application (2017-2028)

    Chapter 6 Global Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export, by Region (2017-2022)

    • 6.1 China Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • 6.2 North America Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • 6.3 Europe Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • 6.4 APAC Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • 6.5 Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    Chapter 7 North America Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 7.1 North America Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 7.2 North America Neuromuscular Blocking Agent (NMBA) Market, by Application

    • 7.3 North America Neuromuscular Blocking Agent (NMBA) Market Analysis and Forecast, by Country

      • 7.3.1 United States Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.2 Canada Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 7.3.3 Mexico Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 8 Europe Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 8.1 Europe Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 8.2 Europe Neuromuscular Blocking Agent (NMBA) Market, by Application

    • 8.3 Europe Neuromuscular Blocking Agent (NMBA) Market Analysis and Forecast, by Country

      • 8.3.1 Germany Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.2 UK Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.3 France Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.4 Italy Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.5 Nordic Countries Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.6 Spain Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.7 Belgium Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.8 Poland Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.9 Russia Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 8.3.10 Turkey Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 9 APAC Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 9.1 APAC Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 9.2 APAC Neuromuscular Blocking Agent (NMBA) Market, by Application

    • 9.3 APAC Neuromuscular Blocking Agent (NMBA) Market Analysis and Forecast, by Country

      • 9.3.1 China Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.2 Japan Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.3 Australia and New Zealand Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.4 India Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.5 ASEAN Countries Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 9.3.6 South Korea Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 10 Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market Analysis

    • 10.1 Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market, by Type

    • 10.2 Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market, by Application

    • 10.3 Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Market Analysis and Forecast, by Country

      • 10.3.1 GCC Countries Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.2 Brazil Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.3 Nigeria Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.4 South Africa Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

      • 10.3.5 Argentina Neuromuscular Blocking Agent (NMBA) Sales Volume, Sales Value and Growth Rate (2017-2028)

    Chapter 11 Global and China Neuromuscular Blocking Agent (NMBA) Company Profiles

      • 11.1 Abbott Laboratories

        • 11.1.1 Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.1.2 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.1.3 Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.2 Hengrui Pharmaceutical

        • 11.2.1 Hengrui Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.2.2 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.2.3 Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.3 Somerset Therapeutics

        • 11.3.1 Somerset Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.3.2 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.3.3 Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.4 Guike Pharmaceutical

        • 11.4.1 Guike Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.4.2 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.4.3 Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.5 GlaxoSmithKline

        • 11.5.1 GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.5.2 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.5.3 GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.6 Nanjing King-Friend

        • 11.6.1 Nanjing King-Friend Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.6.2 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.6.3 Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.7 Sandoz

        • 11.7.1 Sandoz Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.7.2 Sandoz Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.7.3 Sandoz Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.8 Fresenius Kabi

        • 11.8.1 Fresenius Kabi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.8.2 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.8.3 Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.9 AbbVie

        • 11.9.1 AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.9.2 AbbVie Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.9.3 AbbVie Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.10 Pfizer

        • 11.10.1 Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.10.2 Pfizer Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.10.3 Pfizer Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.11 Shanghai Pharmaceuticals

        • 11.11.1 Shanghai Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.11.2 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.11.3 Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

      • 11.12 Themis Medicare

        • 11.12.1 Themis Medicare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

        • 11.12.2 Themis Medicare Neuromuscular Blocking Agent (NMBA) Product Profiles, Application and Specification

        • 11.12.3 Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    Chapter 12 Neuromuscular Blocking Agent (NMBA) Industry Investment Prospect and Risk Assessment

    • 12.1 Neuromuscular Blocking Agent (NMBA) Industry Investment Prospect Assessment

      • 12.1.1 Investment Opportunities in Segmented Markets

      • 12.1.2 Investment Opportunities in Regional Markets

      • 12.1.3 Investment Opportunities in Subdivided Industries

    • 12.2 Neuromuscular Blocking Agent (NMBA) Industry Investment Risk Assessment

      • 12.2.1 Competitive Risk Analysis

      • 12.2.2 Technology Risk Analysis

      • 12.2.3 Policies and Enterprise System Risk Analysis

    List of Tables and Figures

    • Figure Global Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Production Value and Growth Rate (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production Value and Growth Rate (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Depolarizing (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Non-depolarizing (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Hospital (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Clinic (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Pharmacy (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Market Size and Growth Rate of Others (2017-2028)

    • Figure North America Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Europe Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure APAC Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Consumption Market Size and Growth Rate (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Sales Volume, Price, Sales Value, Gross and Gross Margin (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume, Price, Sales Value (2017-2028)

    • Figure Porter's Five Forces Model Analysis

    • Figure Industry PEST Analysis

    • Table Global and China Neuromuscular Blocking Agent (NMBA) Sales Volume, by Manufacturer (2021&2022)

    • Table Global and China Neuromuscular Blocking Agent (NMBA) Sales Value, by Manufacturer (2021&2022)

    • Table Global and China Neuromuscular Blocking Agent (NMBA) Market Share, by Manufacturer (2021&2022)

    • Figure Global and China Neuromuscular Blocking Agent (NMBA) Market Share, by Manufacturer in 2021

    • Figure Global and China Neuromuscular Blocking Agent (NMBA) Market Share, by Manufacturer in 2022

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Volume, by Type (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Value, by Type (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Value Share, by Type (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Price Trend, by Type (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Volume, by Type (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Value, by Type (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Value Share, by Type (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Price Trend, by Type (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Volume, by Application (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Value, by Application (2017-2028)

    • Table Global Neuromuscular Blocking Agent (NMBA) Sales Value Share, by Application (2017-2028)

    • Figure Global Neuromuscular Blocking Agent (NMBA) Sales Value Share, by Application (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Volume, by Application (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Value, by Application (2017-2028)

    • Table China Neuromuscular Blocking Agent (NMBA) Sales Value Share, by Application (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Value Share, by Application (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • Figure North America Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • Figure Europe Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • Figure APAC Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • Figure Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Production, Import, Consumption and Export (2017-2022)

    • Table North America Neuromuscular Blocking Agent (NMBA) Sales Volume, by Type (2017-2028)

    • Table North America Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Figure North America Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Table North America Neuromuscular Blocking Agent (NMBA) Sales Volume, by Application (2017-2028)

    • Table North America Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure North America Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure United States Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure United States Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Canada Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Canada Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Mexico Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Mexico Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Table Europe Neuromuscular Blocking Agent (NMBA) Sales Volume, by Type (2017-2028)

    • Table Europe Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Figure Europe Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Table Europe Neuromuscular Blocking Agent (NMBA) Sales Volume, by Application (2017-2028)

    • Table Europe Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure Europe Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure Germany Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Germany Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure UK Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure UK Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure France Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure France Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Italy Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Italy Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Nordic Countries Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Nordic Countries Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Spain Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Spain Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Belgium Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Belgium Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Poland Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Poland Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Russia Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Russia Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Turkey Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Turkey Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Table APAC Neuromuscular Blocking Agent (NMBA) Sales Volume, by Type (2017-2028)

    • Table APAC Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Figure APAC Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Table APAC Neuromuscular Blocking Agent (NMBA) Sales Volume, by Application (2017-2028)

    • Table APAC Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure APAC Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure China Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Japan Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Japan Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Australia and New Zealand Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure India Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure India Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure ASEAN Countries Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure ASEAN Countries Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure South Korea Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure South Korea Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Table Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales Volume, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Figure Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Type (2017-2028)

    • Table Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales Volume, by Application (2017-2028)

    • Table Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure Latin America, Middle East and Africa Neuromuscular Blocking Agent (NMBA) Sales Volume Share, by Application (2017-2028)

    • Figure GCC Countries Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure GCC Countries Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Brazil Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Brazil Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Nigeria Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Nigeria Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure South Africa Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure South Africa Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Figure Argentina Neuromuscular Blocking Agent (NMBA) Sales Volume and Growth Rate (2017-2028)

    • Figure Argentina Neuromuscular Blocking Agent (NMBA) Sales Value and Growth Rate (2017-2028)

    • Table Abbott Laboratories Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Abbott Laboratories Product Profiles, Application and Specification

    • Table Abbott Laboratories Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Hengrui Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Hengrui Pharmaceutical Product Profiles, Application and Specification

    • Table Hengrui Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Somerset Therapeutics Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Somerset Therapeutics Product Profiles, Application and Specification

    • Table Somerset Therapeutics Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Guike Pharmaceutical Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Guike Pharmaceutical Product Profiles, Application and Specification

    • Table Guike Pharmaceutical Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table GlaxoSmithKline Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table GlaxoSmithKline Product Profiles, Application and Specification

    • Table GlaxoSmithKline Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Nanjing King-Friend Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Nanjing King-Friend Product Profiles, Application and Specification

    • Table Nanjing King-Friend Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Sandoz Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Sandoz Product Profiles, Application and Specification

    • Table Sandoz Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Fresenius Kabi Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Fresenius Kabi Product Profiles, Application and Specification

    • Table Fresenius Kabi Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table AbbVie Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table AbbVie Product Profiles, Application and Specification

    • Table AbbVie Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Pfizer Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Pfizer Product Profiles, Application and Specification

    • Table Pfizer Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Shanghai Pharmaceuticals Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Shanghai Pharmaceuticals Product Profiles, Application and Specification

    • Table Shanghai Pharmaceuticals Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

    • Table Themis Medicare Basic Information, Plants Distribution, Sales Region, Competitors and Market Position

    • Table Themis Medicare Product Profiles, Application and Specification

    • Table Themis Medicare Neuromuscular Blocking Agent (NMBA) Sales Volume, Revenue, Price, Gross and Gross Margin (2017-2022)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US